Company intelligence / Profile preview

Bayland Capital

Ownership: Private
Development stage: Other

Overview

Bayland Capital is an active investment firm and corporate venture capital arm backed by Pharmaron. It focuses on equity investments in the life sciences sector globally, including biotechnology, pharmaceutical R&D services, and medical device companies. The firm leverages its industrial background and expertise to support innovative biomedical ventures[2][6]. It has made at least 18 investments since its founding in 2019[1].

Industry: Investors

Partnerships

Invests alongside major firms such as Johnson & Johnson InnovationAstraZeneca CICC HealthcareBioTrack CapitalLAV FundMRL Ventures Fund

Beyond the preview

Go deeper on Bayland Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bayland Capital.

Explore the full profile